Episode 142

full
Published on:

7th Mar 2024

Precipio, Inc. (PRPO) Ilan Danieli, CEO

Precipio is a healthcare biotechnology company

focused on cancer diagnostics. Our mission is to address the pervasive problem

of cancer misdiagnoses by developing solutions in the form of diagnostic

products and services. Our products and services deliver higher accuracy,

improved laboratory workflow, and ultimately better patient outcomes, which

reduce healthcare expenses. Precipio develops innovative technologies in our

laboratory where we design, test, validate, and use these products clinically,

improving diagnostic outcomes. Precipio then commercializes these technologies

as proprietary products that serve the global laboratory community and further

scales Precipio’s reach to eradicate misdiagnosis. 

Next Episode All Episodes Previous Episode

Listen for free

Show artwork for The Wall Street Resource

About the Podcast

The Wall Street Resource
Your resource for microcap discovery and due diligence
As part of the investment process, we have conducted countless CEO and executive interviews, and found this to be an invaluable use of time. We provide The Wall Street Resource, not only to help you leverage your time, but for discovery and a starting point for due diligence.

About your host

Profile picture for Jeffrey Kone

Jeffrey Kone

Managing Member and portfolio manager of a micro-cap fund for over 15 years. Securities experience that encompasses almost all aspects of the industry (buy side, sell side, retail, institutional and investment banking). Degree from University of Southern California with a Bachelor of Science in Business, emphasis in Entrepreneurship.